SCHEMBL460013

SCHEMBL460013

CC(Oc1ncc(Cl)cc1-c1ccc(Cl)cc1)C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 5/20 0.45
MAP4K4 O95819 3/20 0.41
CNR1 P21554 3/20 0.40
S1PR1 P21453 1/20 0.39
S1PR3 Q99500 1/20 0.39
S1PR5 Q9H228 1/20 0.39
LMNA P02545 2/20 0.36
FFAR4 Q5NUL3 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
POLB P06746 1/20 0.36
HPGD P15428 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
RORC P51449 1/20 0.36
METAP2 P50579 1/20 0.36
CNR2 P34972 1/20 0.34
LRRK2 Q5S007 1/20 0.34
AAK1 Q2M2I8 2/20 0.34
CYP2C9 P11712 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL412123 1.00 PTGS2 (0.45) PTGS2MAP4K4CNR1S1PR1S1PR3
SCHEMBL2115645 0.89 MAP4K4 (0.43) PTGS2MAP4K4CNR1S1PR1S1PR3
SCHEMBL9978236 0.85 CNR1 (0.48) PTGS2MAP4K4CNR1S1PR1S1PR3
SCHEMBL439869 0.85 CNR1 (0.48) PTGS2MAP4K4CNR1S1PR1S1PR3
SCHEMBL410515 0.85 CNR1 (0.48) PTGS2MAP4K4CNR1S1PR1S1PR3
SCHEMBL412128 0.83 CNR1 (0.49) PTGS2CNR1S1PR1S1PR3S1PR5
SCHEMBL440364 0.83 CNR1 (0.49) PTGS2CNR1S1PR1S1PR3S1PR5
SCHEMBL2114326 0.79 PTGS2 (0.41) PTGS2MAP4K4CNR1S1PR1S1PR3
SCHEMBL2114328 0.79 PTGS2 (0.41) PTGS2MAP4K4CNR1S1PR1S1PR3
SCHEMBL2114466 0.77 MAP4K4 (0.39) MAP4K4CNR1S1PR1S1PR3S1PR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8729105-B2 Heteroarylmethyl amides HOFFMANN LA-ROCHE INC. (US) 2014-05-20 US disclosed
US-20120065212-A1 HETEROARYLMETHYL AMIDES F. HOFFMANN-LA ROCHE AG (CH) 2012-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120065212-A1 HETEROARYLMETHYL AMIDES APOB, LDLR, HMGCR PTGS2 2497/4885MAP4K4 4374/4885CNR1 269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.